While the healthcare consumer is increasingly seeking price information prior to seeking care, the industry lags behind in the provision of that information.

Partner, Health and Life Sciences, Oliver Wyman

The demand for managed long-term services and support is up, and expected to climb higher. What payers need to know about managing this complex line of business.

Partner, Health and Life Sciences, Oliver Wyman

Two scenarios for how repeal and replace changes might unfold.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Six reasons why Medicaid MCOs are killing it on the exchange.

Partner, Health and Life Sciences, Oliver Wyman

Efforts that companies are making to provide more effective health information for vulnerable individuals within their employee populations.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Leaders of financial investment firms share their views on funding companies that provide health information to vulnerable populations.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

A perspective on how pediatric healthcare providers are changing their financial and care models in the evolving value-based market to lower costs and improve outcomes in children’s health.

Former Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Trion/MMA

Insights into how hospital systems can manage Medicaid populations without abandoning their mission – or their bottom line.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Access here our full series examining the increasing role providers are playing in government programs and risk management.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

More and more, we are seeing health systems and physician groups move up the value chain and become risk managers, rather than volume-drivers.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Insights in your inbox

Subscribe
Load More